HIV‐1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
HIV-1 transactivator Tat uses cellular acetylation signalling by targeting several cellular histone acetyltransferases (HAT) to optimize its various functions. Although Tip60 was the first HAT identified to interact with Tat, the biological significance of this interaction has remained obscure. We had previously shown that Tat represses Tip60 HAT activity. Here, a new mechanism of Tip60 neutralization by Tat is described, where Tip60 is identified as a substrate for the newly reported p300/CBP-associated E4-type ubiquitin-ligase activity, and Tat uses this mechanism to induce the polyubiquitination and degradation of Tip60. Tip60 targeting by Tat results in a dramatic impairment of the Tip60-dependent apoptotic cell response to DNA damage. These data reveal yet unknown strategies developed by HIV-1 to increase cell resistance to genotoxic stresses and show a role of Tat as a modulator of cellular protein ubiquitination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Involvement of the TIP60 Histone Acetylase Complex in DNA Repair and Apoptosis
Ikura, T., Ogryzko, V. V., Grigoriev, M., Groisman, R., Wang, J., Horikoshi, M., Scully, R., Qin, J., & Nakatani, Y. (2000) · Cell · doi:10.1016/s0092-8674(00)00051-9 · Cited by 1,029
MDM2–HDAC1-mediated deacetylation of p53 is required for its degradation
Ito, A., Kawaguchi, Y., Lai, C., Kovacs, J. J., Higashimoto, Y., Appella, E., & Yao, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf616 · Cited by 570 · cited 2×
“Moreover, it was shown that p53 acetylation controls its stability (Ito et al, 2002).”
BackgroundAcetylation of p53 inhibits its ubiquitination by Mdm2
Li, M., Luo, J., Brooks, C. L., & Gu, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200578200 · Cited by 503
The acetyltransferase activity of CBP stimulates transcription
Martínez‐Balbás, M. A., Bannister, A. J., Martin, K., Haus‐Seuffert, P., Meisterernst, M., & Kouzarides, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.10.2886 · Cited by 266 · cited 1×
“…from Dr D Bohman, Dr M Benkirane and Dr B Vogelstein, respectively. pSG-Myc p300 wt and mutants, kindly provided by Dr HG Stunnenberg, are described by Mitsiou and Stunnenberg (2003). pGal4-CBP wt and mutants were kind gifts from Dr T Kouzarides and are described by Martinez-Balbas et al (1998).”
Method
Cited by
The MYST family of histone acetyltransferases and their intimate links to cancer
Avvakumov, N., & Côté, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210608 · Cited by 353
Tip60 in DNA damage response and growth control: many tricks in one HAT
Squatrito, M., Gorrini, C., & Amati, B. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.07.007 · Cited by 309
Sapountzi, V., Logan, I. R., & Robson, C. N. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.03.003 · Cited by 283
Regulation of STAT signaling by acetylation
Zhuang, S. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.05.007 · Cited by 195
Jha, S., Vande Pol, S., Banerjee, N. S., Dutta, A. B., Chow, L. T., & Dutta, A. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.020 · Cited by 120
Metadata
- Authors
- Col, E., Caron, C., Chable‐Bessia, C., Legube, G., Gazzeri, S., Komatsu, Y., Yoshida, M., Benkirane, M., Trouche, D., & Khochbin, S.
- Venue
- The EMBO Journal
- Published
- 2005-07-07
- Volume
- 24
- Issue
- 14
- Pages
- 2634-2645
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2115667633
- Cited by
- 96
- References
- 4
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.